Compare2 funds · 1 pair
Picked · 2YTD
XBIvsARKGVersus · 5Y · 12.8% held in common6–0measures won
Close to theseFee · YTD
Best of the twoNov 3
  • Lowest cost$ a year on $10kXBI 0.35%
  • Most incometrailing 12-month yieldXBI 0.35%
  • Best 5 yearsper yearXBI +4.7%
  • Smallest drop · 1Yworst fall in the past yearXBI −14.9%
Measures won6–0XBI wins · of 6 · 5Y
$10,000 · 5Y$12,576XBI · ARKG $6,586
Lowest cost0.35%XBI · $35 on $10k
Most income0.35%XBI · $35 on $10k
Smallest drop−14.9%XBI · worst fall in 1Y
Held in common12.8%XBI and ARKG

XBI vs ARKG

5Y
XBI
ARKG
State Street SPDR S&P Biotech ETF · $10.5BARK Genomic Revolution ETF · $2.2B
+34.5%3 years · per year$24,320 · $22,262+30.6%
+4.7%5 years · per year$12,576 · $6,586−8.0%
0.35%Expense ratio$35 · $75 on $10k · lower wins0.75%
0.35%12-mo yield$35 · $0 on $10k0.00%
−14.9%Worst dropSmaller wins−27.5%
29.1%VolatilityLower wins45.8%
6–0XBI wins
$10,000 · 5 yearsOne scale
$10k startXBI $12.6kARKG $6.6kOct 2021Nov 2026
Shared top holdingsXBI · ARKG
2.0%TWST7.4%
1.9%NTRA4.7%
1.4%CRSP5.5%
1.2%VCYT3.8%
Held in common12.8%
End-of-day Nov 3, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1AXBIState Street SPDR S&P Biotech ETFReadDesk0.35%0.35%+1.9%+27.2%+38.1%+34.5%+4.7%−14.9%$10.5B
2BARKGARK Genomic Revolution ETFReadDesk0.75%0.00%+2.5%+70.9%+59.0%+30.6%−8.0%−27.5%$2.2B
End-of-day Nov 3, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

XBI vs ARKG

5Y
SPDR S&P Biotech
$12,576
ARK Genomic Revolution
$6,586
$5k$10kNov 2021Nov 2026$12,576$6,586$5k$10kNov 2021Nov 2026$12,576$6,586
MeasureXBIARKG
Fee0.35%0.75%
Cost on $10k a year$35$75
Yield0.35%0.00%
5 years, per year+4.7%−8.0%
3 years, per year+34.5%+30.6%
Worst drop · 1Y−14.9%−27.5%
Volatility · 1Y29.1%45.8%
6–0measures won
XBI first
12.8%
holdings shared
Nov 3, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+32.8%
VIGVanguard
+14.0%
Jan 1Nov 3+32.8%+14.0%
+32.8%Year to date+14.0%
3.0%Yield1.5%
$121BAssets$109B
2–0SCHD wins
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+7.5%
JEPIJ.P. Morgan
+7.0%
Jan 1Nov 3+7.5%+7.0%
+7.5%Year to date+7.0%
12.3%Yield8.0%
$41.8BAssets$46.0B
2–0JEPQ wins
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+11.5%
SPYSPDR
+11.5%
Jan 1Nov 3+11.5%+11.5%
+11.5%Year to date+11.5%
1.0%Yield1.0%
$185BAssets$798B
0–0level
End-of-day Nov 3, 2026
@TheETFTracker·theetftracker.com

Overlap: XBI, ARKG

Today
12.8%most shared, XBI and ARKG
XBIARKG
XBI—12.8%
ARKG12.8%—
End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$0most kept, XBI
XBI$35 − $35 = $0
ARKG$0 − $75 = −$75
KeptFee
End-of-day Nov 3, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com